Literature DB >> 6833470

Reduced bone mineral content in totally thyroidectomized patients: possible effect of calcitonin deficiency.

M T McDermott, G S Kidd, P Blue, V Ghaed, F D Hofeldt.   

Abstract

To further investigate the relationship between calcitonin deficiency and osteoporosis, we have measured bone mineral content (BMC) by single photon absorptiometry in patients made iatrogenically calcitonin deficient by prior total thyroidectomy for thyroid cancer. Compared to sex-, age-, height-, and weight-matched normal controls, male patients had a significantly lower mean BMC at the midradius (1.162 +/- 0.02 vs. 1.301 +/- 0.05 g/cm; P less than 0.02) and the distal radius (1.180 +/- 0.04 vs. 1.338 +/- 0.04 g/cm; P less than 0.01). Female patients also had a significantly lower BMC at the midradius compared to those of a similarly matched group of normal controls and a group of patients on L-T4 suppression for nodular goiters (0.791 +/- 0.04 vs. 0.896 +/- 0.05 vs. 0.891 +/- 0.03 g/cm; P less than 0.025). We conclude that calcitonin deficiency from surgical thyroidectomy is associated with significant decreases in bone mineral content in both sexes. This lends further support to the concept that calcitonin deficiency may be an important causative factor in the development of osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833470     DOI: 10.1210/jcem-56-5-936

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Calcitonin and estrogens.

Authors:  D Agnusdei; R Civitelli; A Camporeale; C Gennari
Journal:  J Endocrinol Invest       Date:  1990-09       Impact factor: 4.256

2.  Effect of calcitonin deficiency on bone density and bone turnover in totally thyroidectomized patients.

Authors:  P Schneider; P Berger; K Kruse; W Börner
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

3.  Calcitonin and bone mass status in congenital hypothyroidism.

Authors:  N Demeester-Mirkine; P Bergmann; J J Body; J Corvilain
Journal:  Calcif Tissue Int       Date:  1990-04       Impact factor: 4.333

4.  Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene.

Authors:  Ana O Hoff; Philip Catala-Lehnen; Pamela M Thomas; Matthias Priemel; Johannes M Rueger; Igor Nasonkin; Allan Bradley; Mark R Hughes; Nelson Ordonez; Gilbert J Cote; Michael Amling; Robert F Gagel
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

5.  Altered calcitonin gene in a young patient with osteoporosis.

Authors:  M Alevizaki; J C Stevenson; S I Girgis; I MacIntyre; S Legon
Journal:  BMJ       Date:  1989-05-06

6.  Racial differences in calcitonin and katacalcin.

Authors:  J C Stevenson; C H Myers; A B Ajdukiewicz
Journal:  Calcif Tissue Int       Date:  1984-12       Impact factor: 4.333

7.  Presymptomatic detection and treatment of Japanese carriers of the multiple endocrine neoplasia type 2A gene.

Authors:  S Uchino; S Noguchi; M Sato; M Adachi; H Yamashita; S Watanabe; T Murakami; M Toda; N Murakami; H Yamashita
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

8.  Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma.

Authors:  G Görres; A Kaim; A Otte; M Götze; J Müller-Brand
Journal:  Eur J Nucl Med       Date:  1996-06

9.  A longitudinal assessment of bone loss in women with levothyroxine-suppressed benign thyroid disease and thyroid cancer.

Authors:  M T McDermott; J J Perloff; G S Kidd
Journal:  Calcif Tissue Int       Date:  1995-06       Impact factor: 4.333

10.  Spinal bone mass after long-term treatment with L-thyroxine in postmenopausal women with thyroid cancer and chronic lymphocytic thyroiditis.

Authors:  F Hawkins; D Rigopoulou; K Papapietro; M B Lopez
Journal:  Calcif Tissue Int       Date:  1994-01       Impact factor: 4.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.